These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 21102330)

  • 1. Possible contributions of lipoproteins and cholesterol to the pathogenesis of diabetes mellitus type 2.
    von Eckardstein A; Sibler RA
    Curr Opin Lipidol; 2011 Feb; 22(1):26-32. PubMed ID: 21102330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HDL and LDL cholesterol significantly influence beta-cell function in type 2 diabetes mellitus.
    Kruit JK; Brunham LR; Verchere CB; Hayden MR
    Curr Opin Lipidol; 2010 Jun; 21(3):178-85. PubMed ID: 20463468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of plasma triglycerides in insulin resistance and diabetes.
    Ginsberg HN; Zhang YL; Hernandez-Ono A
    Arch Med Res; 2005; 36(3):232-40. PubMed ID: 15925013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
    Petersen KR
    Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of lipases, lecithin:cholesterol acyltransferase and cholesteryl ester transfer protein in abnormal high density lipoprotein metabolism in insulin resistance and type 2 diabetes mellitus.
    de Vries R; Borggreve SE; Dullaart RP
    Clin Lab; 2003; 49(11-12):601-13. PubMed ID: 14651331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Idiopathic hypertriglyceridemia].
    Kotake H; Oikawa S
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():79-87. PubMed ID: 11347174
    [No Abstract]   [Full Text] [Related]  

  • 7. Insulin resistance is independently associated with postprandial alterations of triglyceride-rich lipoproteins in type 2 diabetes mellitus.
    Annuzzi G; De Natale C; Iovine C; Patti L; Di Marino L; Coppola S; Del Prato S; Riccardi G; Rivellese AA
    Arterioscler Thromb Vasc Biol; 2004 Dec; 24(12):2397-402. PubMed ID: 15458975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-cell function and mass in type 2 diabetes.
    Larsen MO
    Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HDLs, diabetes, and metabolic syndrome.
    Vollenweider P; von Eckardstein A; Widmann C
    Handb Exp Pharmacol; 2015; 224():405-21. PubMed ID: 25522996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Insulin resistance in pancreatic beta-cells: possible implication in beta-cell glucose toxicity].
    Kaneto H; Kawamori D; Matsuoka TA
    Nihon Rinsho; 2006 Dec; 64 Suppl 9():203-11. PubMed ID: 17458219
    [No Abstract]   [Full Text] [Related]  

  • 11. [Disorders of lipid metabolism in insulin resistance].
    Müller-Wieland D; Krone W
    Herz; 1995 Feb; 20(1):33-46. PubMed ID: 7713475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Dyslipoproteinemia and metabolic syndrome. Effects of insulin resistance and hyperinsulinemia on lipid metabolism].
    Krone W; Müller-Wieland D; Wirth H
    Fortschr Med; 1992 Dec; 110(34):645-8. PubMed ID: 1483617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoprotein metabolism mediates the association of MTP polymorphism with beta-cell dysfunction in healthy subjects and in nondiabetic normolipidemic patients with nonalcoholic steatohepatitis.
    Musso G; Gambino R; Cassader M
    J Nutr Biochem; 2010 Sep; 21(9):834-40. PubMed ID: 19733470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dyslipidemias in patients with diabetes mellitus: classification and risks and benefits of therapy.
    Oki JC
    Pharmacotherapy; 1995; 15(3):317-37. PubMed ID: 7667166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear magnetic resonance lipoprotein abnormalities in prediabetic subjects in the Insulin Resistance Atherosclerosis Study.
    Festa A; Williams K; Hanley AJ; Otvos JD; Goff DC; Wagenknecht LE; Haffner SM
    Circulation; 2005 Jun; 111(25):3465-72. PubMed ID: 15983261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenesis of dyslipidemia in type 2 diabetes.
    Taskinen MR
    Exp Clin Endocrinol Diabetes; 2001; 109 Suppl 2():S180-8. PubMed ID: 11460569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fate of the beta-cell in the pathophysiology of type 2 diabetes.
    Campbell RK
    J Am Pharm Assoc (2003); 2009; 49 Suppl 1():S10-5. PubMed ID: 19801360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic disorders in children and adolescents with type 2 diabetes mellitus.
    Huang CY; Li HJ; Lo FS; Wang AM; Shih BF; Lin CH; Chen MR; Lee HC; Lee YJ
    Acta Paediatr Taiwan; 2006; 47(4):187-91. PubMed ID: 17180786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma relaxin concentration is related to beta-cell function and insulin sensitivity in women with type 2 diabetes mellitus.
    Szepietowska B; Gorska M; Szelachowska M
    Diabetes Res Clin Pract; 2008 Mar; 79(3):e1-3. PubMed ID: 18035445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bariatric surgery: what is the effect on type 2 diabetes?
    Dar M; Pories WJ
    Curr Opin Investig Drugs; 2009 Oct; 10(10):1078-84. PubMed ID: 19777396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.